insights_auto
Why is IKT up ३.१४%?
Dive Deeperchevron_right
IKT:NASDAQ
Inhibikase Therapeutics Inc
US$ १.९७
arrow_upward
+३.१४%(+०.०६०) 1D
US$ १.९७
०.००% (०.००)
bedtimeAfter hours
Closed: अक्टोबर ९, १६:००:०१ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IKT...
Open
US$ १.९०
High
US$ १.९८
Low
US$ १.८७
Mkt. cap
२७.४९ करोड
Avg. vol.
५.१८ लाख
Volume
०.००
52-wk high
US$ २.६१
52-wk low
US$ १.३३
EPS
-US$ ०.४४
Beta
०.८९
Shares outstanding
१३.९५ करोड
No. of employees
३५
Open
US$ १.९०
High
US$ १.९८
Low
US$ १.८७
Mkt. cap
२७.४९ करोड
Avg. vol.
५.१८ लाख
Volume
०.००
52-wk high
US$ २.६१
52-wk low
US$ १.३३
EPS
-US$ ०.४४
Beta
०.८९
Shares outstanding
१३.९५ करोड
No. of employees
३५
News stories
From web sources and news partners
Business Wire
·
५ मिनेट पहिले
Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard
Yahoo Finance
·
१ घण्टा पहिले
UPDATED: TruGolf Completes Acquisition of Polymath Research, Bringing a Blockchain Purpose-Built for Regulated Assets to Nasdaq
SpaceQ
·
५८ मिनेट पहिले
NorthStar rings NYSE bell, adds U.S. technical director
GuruFocus
·
३ घण्टा पहिले
S&P 500, Dow and Nasdaq Rise After Steep AI Sell-Off
About Inhibikase Therapeutics Inc
CEO-
Employees३५
Founded२००८
HeadquartersWilmington, डेलावेयर, संयुक्त राज्य अमेरिका
Sector-
Websiteinhibikase.com